Cloverleaf Strategies provides end-to-end strategic support for tough commercial challenges spanning from business opportunity assessments to the development of early assets through identifying competitive advantage to drive in-market performance. Cloverleaf partners with biopharmaceutical companies to ensure oncology therapeutics realize their potential through strategic growth and sustainable differentiation by leveraging the intersection between deep scientific understanding and commercial expertise.

🔗 http://cloverleafstrat.com

CONNECT:

John Dunn, Principal
📧 JohnDunn@cloverleafstrat.com
📞 609.760.0921
716 Walton Court
Moorestown, NJ 08054